Contact
Please use this form to send email to PR contact of this press release:
Merck and Samsung Bioepis Announce Approval of BRENZYS™ (Etanercept), a Biosimilar of Enbrel, in Korea
TO:
Please use this form to send email to PR contact of this press release:
Merck and Samsung Bioepis Announce Approval of BRENZYS™ (Etanercept), a Biosimilar of Enbrel, in Korea
TO: